Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

LEIDOS HOLDINGS, INC.

(LDOS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Leidos : Argus Adjusts Leidos Holdings' Price Target to $118 From $100, Reiterates Buy Rating

06/02/2021 | 09:59am EDT


ę MT Newswires 2021
All news about LEIDOS HOLDINGS, INC.
11:01aParsons-Led Team Wins $953 Million Contract to Protect US Air Force Bases
MT
07/14Leidos UK Appoints Lieutenant General Darrell K. Williams (Ret.) to Vice Pres..
CI
07/12LEIDOS HOLDINGS, INC. : Entry into a Material Definitive Agreement, Creation of ..
AQ
07/08LEIDOS : launches $1 million ‘Move the Needle' employee vaccine sweepstake..
PU
07/07LEIDOS : launches $1 million 'Move the Needle' employee vaccine sweepstakes
PR
07/01LEIDOS : Announces Leadership Changes as Part of Ongoing Optimization Efforts
PR
07/01Leidos Announces Leadership Changes as Part of Ongoing Optimization Efforts
CI
07/01LEIDOS : Named to Forbes' List of America's Best Employers for Diversity
PR
06/30LEIDOS : Awarded $2.5 Billion NASA Contract for IT Operations
MT
06/30LEIDOS : awarded $2.5 billion contract to support NASA's enterprise IT operation..
PU
More news
Financials (USD)
Sales 2021 13 949 M - -
Net income 2021 778 M - -
Net Debt 2021 4 242 M - -
P/E ratio 2021 19,8x
Yield 2021 1,33%
Capitalization 15 050 M 15 050 M -
EV / Sales 2021 1,38x
EV / Sales 2022 1,27x
Nbr of Employees 39 000
Free-Float 99,2%
Chart LEIDOS HOLDINGS, INC.
Duration : Period :
Leidos Holdings, Inc. Technical Analysis Chart | LDOS | US5253271028 | MarketScreener
Technical analysis trends LEIDOS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 106,42 $
Average target price 117,92 $
Spread / Average Target 10,8%
EPS Revisions
Managers and Directors
Roger A. Krone Chairman & Chief Executive Officer
James Corbett Reagan Chief Financial Officer & Executive VP
Donald Kosiak Chief Medical Officer
Steve Hull Chief Information Officer & Senior Vice President
James F. Carlini Chief Technology Officer
Sector and Competitors